ClinicalTrialsFinder

Hypoparathyroidism Clinical Trials in Reno, Nevada

1 recruitingReno, Nevada

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

HypoparathyroidismEndocrine System DiseasesParathyroid Diseases
Ascendis Pharma Bone Diseases A/S36 enrolled2 locationsNCT07081997